Filing Details
- Accession Number:
- 0001104659-25-024063
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-14 18:21:44
- Reporting Period:
- 2025-03-13
- Filing Date:
- 2025-03-14
- Accepted Time:
- 2025-03-14 18:21:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1377121 | Protagonist Therapeutics Inc | PTGX | Pharmaceutical Preparations (2834) | 980505495 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1398940 | Md Arturo Molina | C/O Protagonist Therapeutics, Inc. 7707 Gateway Blvd., Suite 140 Newark CA 94560-1160 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-13 | 28,437 | $23.42 | 112,329 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-03-13 | 2,077 | $38.98 | 114,406 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-03-13 | 30,514 | $55.74 | 83,892 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2025-03-13 | 28,437 | $0.00 | 28,437 | $23.42 |
| Common Stock | Stock Option (right to buy) | Disposition | 2025-03-13 | 2,077 | $0.00 | 2,077 | $38.98 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 69,063 | 2034-01-02 | No | 4 | M | Direct | |
| 47,785 | 2035-01-02 | No | 4 | M | Direct |
Footnotes
- The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $55.245 to $56.06. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- The stock option vests in 48 equal monthly installments following January 2, 2024, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
- The stock option vests in 48 equal monthly installments following January 2, 2025, subject to the Reporting Person's continued service to the Issuer through each applicable vesting date.
Billionaire Hedge Funds
